| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/19/1996 | CN1124637A Dingxiansan capsule for curing epilepsy |
| 06/19/1996 | CN1124634A Antitussive Chinese drug and preparing process thereof |
| 06/19/1996 | CN1124632A Prescription of Chinese medicine and producing process thereof |
| 06/19/1996 | CN1124629A Jiedukang instant granule for abstaining from smoking opium and producing process thereof |
| 06/19/1996 | CN1124627A Oral liquid for enhancing immunologic function |
| 06/19/1996 | CN1124621A Wettable powder of niclosamide salt |
| 06/19/1996 | CN1124619A Hard gelatin capsules resistant to denaturation and the production thereof |
| 06/19/1996 | CN1124618A Quick-acting cold oral liquid for child and preparing process thereof |
| 06/19/1996 | CN1124617A Lyophilized bougie and producing process thereof |
| 06/19/1996 | CN1124584A Bioactive feed |
| 06/18/1996 | US5527962 Fluoropolymer with perfluoroalkyl mercaptan end group as carrier for drug delivery |
| 06/18/1996 | US5527928 Cationic transport reagents |
| 06/18/1996 | US5527832 Antiinflammatory and analgesic transdermal gel |
| 06/18/1996 | US5527831 Administering an ophthalmic solution of polyhyroxyalcohol such as sorbitol, mannitol, inositol or xylitol along with carrier to lower pressure |
| 06/18/1996 | US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines |
| 06/18/1996 | US5527802 New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones |
| 06/18/1996 | US5527797 Process for transport of agents across the skin and compositions and articles useful therein |
| 06/18/1996 | US5527783 Dry and Porous galenic form based on plants, its method of preparation and its applications |
| 06/18/1996 | US5527545 Naproxen |
| 06/18/1996 | US5527543 A carrier comprising diluent and binder; a film coating comprising a steroid and a lubricant |
| 06/18/1996 | US5527542 Applying carbohydrate or protein syrup or steam(wetting) to pellet surface, then coating with pure maltitol powder yields protective coatings |
| 06/18/1996 | US5527540 Effervescent granules covering active material, such as ace inhibitor |
| 06/18/1996 | US5527539 Tablets with thioctic acid of specific particle size |
| 06/18/1996 | US5527538 Liposomal targeting of ischemic tissue |
| 06/18/1996 | US5527537 Contains natural oils, 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine and water |
| 06/18/1996 | US5527536 Comprises back layer bonded to insoluble adhesive film consisting of styrene-ethylene-butylene block polymer; time releasing agents |
| 06/18/1996 | US5527534 User-controlled release of drug contained in saturated sponge. a truncated sphere or tampon; for delivering contraceptives, antibiotics, hormones, antiinflammatory agents or cleansing agents |
| 06/18/1996 | US5527532 Extraluminal regulation of the growth and repair of tubular structures in vivo |
| 06/18/1996 | US5527531 Synthetic bait for delivery of chemicals and biologics |
| 06/18/1996 | US5527528 Solid-tumor treatment method |
| 06/18/1996 | US5527521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
| 06/18/1996 | CA2065403C Transdermal delivery device having delayed onset |
| 06/14/1996 | CA2158511A1 Pharmaceutical formulations of cefaclor |
| 06/13/1996 | WO1996017863A1 Induction of cytotoxic t-lymphocyte responses |
| 06/13/1996 | WO1996017621A1 Correcting biological information transfer using three biological information blocks |
| 06/13/1996 | WO1996017615A1 Viscous liquid conditioning topical germicides |
| 06/13/1996 | WO1996017614A1 Adjuvant-incorporated cellular antigens: conjugation and methods |
| 06/13/1996 | WO1996017611A1 Pharmaceutical composition comprising lamotrigine |
| 06/13/1996 | WO1996017607A1 Method of producing a pantoprazol lyophilisate |
| 06/13/1996 | WO1996017603A1 Emulsion suitable for administering a sphingolipid and use thereof |
| 06/13/1996 | WO1996017599A1 Method of drug delivery and coatings for use in the method |
| 06/13/1996 | WO1996017598A1 Diltiazem hydrochloride formulation |
| 06/13/1996 | WO1996017597A1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 06/13/1996 | WO1996017596A1 Liposomal interferon hybrid compositions |
| 06/13/1996 | WO1996017595A1 Foamable formulation and foam |
| 06/13/1996 | WO1996017594A1 Sequestration agents |
| 06/13/1996 | WO1996017593A1 Solubilisation aids for hydrophilic macromolecules |
| 06/13/1996 | WO1996017579A1 N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution |
| 06/13/1996 | WO1996017565A1 Apparatus and method of delivery of gas-supersaturated liquids |
| 06/13/1996 | WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 06/13/1996 | CA2207410A1 Apparatus and method of delivery of gas-supersaturated liquids |
| 06/13/1996 | CA2207292A1 Liposomal interferon hybrid compositions |
| 06/13/1996 | CA2207284A1 Pharmaceutical composition comprising lamotrigine |
| 06/13/1996 | CA2207279A1 Solubilisation aids for hydrophilic macromolecules |
| 06/13/1996 | CA2207274A1 Sequestration agents |
| 06/13/1996 | CA2206691A1 Method of drug delivery and coatings for use in the method |
| 06/13/1996 | CA2204738A1 Induction of cytotoxic t-lymphocyte responses |
| 06/12/1996 | EP0715857A2 Orally applicable pharmaceutical composition containing a water-soluble amino acid as a disintegration accelerator |
| 06/12/1996 | EP0715856A1 Keratin-storable antifungal composition for external use |
| 06/12/1996 | EP0715848A2 Medicine depot containing alginate and a polymeric binding agent |
| 06/12/1996 | EP0715847A2 Sustained release capsule and formulations for insertion into rumen |
| 06/12/1996 | EP0715846A1 Pharmaceutical composition for oral administration containing amino acids |
| 06/12/1996 | EP0715842A2 Water-in-oil-in-water compositions |
| 06/12/1996 | EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 06/12/1996 | EP0715520A1 Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel |
| 06/12/1996 | EP0715516A1 Oral compositions of h 2?-antagonists |
| 06/12/1996 | EP0715515A1 Tablet containing a basic material possibly containing active substances and active substance containing microparticles |
| 06/12/1996 | EP0655900A4 Foam laminate transdermal patch. |
| 06/12/1996 | EP0632692B1 Dispersible products |
| 06/12/1996 | EP0555329B1 Articles having a hydrophilic polymeric shell and method for preparing same |
| 06/12/1996 | CN1124457A Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug |
| 06/12/1996 | CN1124454A Rectal compositions |
| 06/12/1996 | CN1124452A Process |
| 06/12/1996 | CN1124451A Liquid antacid compositions |
| 06/12/1996 | CN1124449A Low-viscosity cosmetic and pharmaceutical emulsions |
| 06/12/1996 | CN1124446A Method and apparatus for diagnosing erectile dysfunction |
| 06/12/1996 | CN1124159A Cobra venom injection and its producing method |
| 06/12/1996 | CN1124158A Health-care article for congenital and acquired vagina coarctation |
| 06/12/1996 | CN1124157A Oral liquor for sobering from wine |
| 06/12/1996 | CN1124156A Nuxingshu Medicine-biological regulating potentiator for curing gynecopathy |
| 06/12/1996 | CN1124155A Zengxueling oral liquor for increasing blood and its preparing method |
| 06/12/1996 | CN1124153A Medicine for recovery and replenishing liver and its preparing method |
| 06/12/1996 | CN1124151A "Guyankang" adhesive plaster for curing osteomyelitis |
| 06/12/1996 | CN1124144A Full scorpion preparation for curing cardio-cerebral vascular nervous system diseases and tumor and its preparing method |
| 06/12/1996 | CN1124143A Powder preparation for healing damaged skin |
| 06/12/1996 | CN1124140A Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration |
| 06/12/1996 | CN1124139A Diazoletan efferrescent tablets and preparing method thereof |
| 06/12/1996 | CN1124136A Apparatus and process for strengthening low density compression dosage units and product therefrom |
| 06/12/1996 | CN1124135A Producing method for vascular embolism porcelain powder |
| 06/11/1996 | US5525634 Colonic drug delivery system |
| 06/11/1996 | US5525631 Compositions of the ethyl ester of L-DOPA |
| 06/11/1996 | US5525359 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation and method for manufacturing these microcapsules and cosmetic or pharmaceutical or food compositions containing them |
| 06/11/1996 | US5525358 Addition of polybutylene increases film flexibility |
| 06/11/1996 | US5525356 Amphoteric N-substituted acrylamide hydrogel and method |
| 06/11/1996 | US5525355 Mixture with stool softener |
| 06/11/1996 | US5525354 Salts of dichloromethylene bisphosphonic acid in drug delivery form with acid-dissolving enteric coating, for oral administration |
| 06/11/1996 | US5525352 Ice cream coating on capsules, controlled release, storage at cold temperature |
| 06/11/1996 | US5525351 Nicotine containing stimulant unit |
| 06/11/1996 | US5525349 Before and after eye surgery treatment applying a steroid antiinflammatory agent, microbiocides |
| 06/11/1996 | US5525329 Inhibition of phosphodiesterase in olfactory mucosa |